Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $86.70 | Total: $433.50 |
| 1 | 10 | $73.44 | Total: $734.40 |
| 1 | 25 | $62.22 | Total: $1,555.50 |
| 1 | 50 | $53.04 | Total: $2,652.00 |
| 1 | 100 | $45.90 | Total: $4,590.00 |
Overview
SCH-900271 is a potent nicotinic acid receptor for the treatment of dyslipidaemia and is commonly used in the study of mixed hyperlipidaemia and primary hypercholesterolaemia.
Chemical Properties
| Molecular Formula | C14H16N2O4 |
| Molecular Weight | 276.29 |
| CAS Numbers | 915210-50-3 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(CCC1(C)CC1)C=2C3=C(NC(=O)NC3=O)OC(=O)C2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Palani A, et al. Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia. ACS Med Chem Lett. 2011 ; 3[1] 63-68.